ArticleCurrent pharmaceutical biotechnology2026
A Fed-batch Process for the Production of Recombinant Adeno-associated Virus (rAAV) Vectors Using the Sf9-Rhabdovirus-negative Cell Line.
Xinran Li et al.PubMed ↗Publisher ↗
No numbers read from the abstract.